KYIV. Nov 16 (Interfax-Ukraine) – Sanofi international pharmaceutical company could return to the realization of production localization investment projects in 2016, Sanofi CEO for Ukraine and Belarus Jean-Paul Scheuer has said.
“Ukraine will become more attractive for investors. In particular, we started investing in the country and the production of four our medicines was localized. Despite the fact that in the past 18 months we slightly suspended the projects, we plan to return to them. We hope that in 2016,” he said in an interview with Interfax-Ukraine.
Sanofi focuses on solutions for diabetes, human vaccines, innovative drugs, consumer health care, emerging markets, animal health, and is also engaged in the development and implementation of advanced technologies for the treatment of life-threatening diseases.
